Daewoong A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of DWN12088 in Patients With Idiopathic Pulmonary Fibrosis
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Daewoong Pharmaceutical Co., Ltd
Start Date
March 22, 2023
End Date
May 31, 2027
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
Daewoong Pharmaceutical Co., Ltd
Start Date
March 22, 2023
End Date
May 31, 2027